You are here: Industry Insights > Regeneron

News List

Sanofi and Regeneron Announce FDA Approval of Dupixent (dupilumab) biospectrumasia
April 05, 2017
Dupixent will be available later this week to U.S. patients suffering from this chronic and debilitating form of eczema
Regeneron and Sanofi announce FDA approval of Dupixent cphi-online
March 31, 2017
First targeted biologic therapy for adults with moderate-to-severe atopic dermatitis.
UK Biobank attracts backing from GSK and Regeneron pharmatimes
March 27, 2017
GlaxoSmithKline and Regeneron have given their backing to a new project that will use patient data held by the UK Biobank.
Regeneron Reports Fourth Quarter and Full Year 2016 Financial and Operating Results americanpharmaceuticalreview
February 13, 2017
Regeneron Pharmaceuticals has announced financial results for the fourth quarter and full year 2016 and provided a business update.
Appeals Court grants stay of permanent injunction for Praluent during appeals process cphi-online
February 13, 2017
Praluent continues to be available to patients in the US.
Regeneron's annual outlook for Eylea sales growth falls short of expectations firstwordpharma
February 10, 2017
Regeneron Pharmaceuticals said Thursday alongside its fourth-quarter financial results that it expects US sales of Eylea to grow by a single-digit percentage this year, below analyst estimates.
Regeneron takes ownership of HQ for $720m after 25 years pharmafile
January 26, 2017
Regeneron plans to finance the deal through a lease financing arrangement for the full amount of $720 million with Banc of America Leasing & Capital

Previous page 1 2 3 4 5 6 7 8 9 10 ... 15 16 Next page